Transcranial magnetic stimulation: what should psychiatrists know?

Detalhes bibliográficos
Autor(a) principal: Montenegro, Maria Cristina
Data de Publicação: 2016
Outros Autores: Cantilino, Amaury
Tipo de documento: Artigo
Idioma: por
Título da fonte: Debates em Psiquiatria (Online)
Texto Completo: https://revistardp.org.br/revista/article/view/131
Resumo: Transcranial magnetic stimulation (TMS) is a noninvasive neuromodulation technique with minimal adverse effects and few contraindications. The procedure has been used in the treatment of patients with depression, with proven therapeutic benefits as shown in studies conducted worldwide. The latest European guideline published on the topic, in 2014, assigns evidence level A (defined efficacy) to high-frequency repetitive TMS applied over the left prefrontal dorsolateral cortex of patients with depression. The technique was approved by the U.S. Food and Drug Administration (FDA) for the treatment of depression in 2008 and recognized in 2012 by Brazilian Council of Medicine as a valid medical procedure throughout the country.
id ABP-2_02d365be674b530dfce59fd5b6815927
oai_identifier_str oai:ojs.emnuvens.com.br:article/131
network_acronym_str ABP-2
network_name_str Debates em Psiquiatria (Online)
repository_id_str
spelling Transcranial magnetic stimulation: what should psychiatrists know?Estimulação magnética transcraniana: o que o psiquiatra deve saber?Estimulação magnética transcraniananeuromodulaçãodepressão maiorTranscranial magnetic stimulationneuromodulationmajor depressive disorderTranscranial magnetic stimulation (TMS) is a noninvasive neuromodulation technique with minimal adverse effects and few contraindications. The procedure has been used in the treatment of patients with depression, with proven therapeutic benefits as shown in studies conducted worldwide. The latest European guideline published on the topic, in 2014, assigns evidence level A (defined efficacy) to high-frequency repetitive TMS applied over the left prefrontal dorsolateral cortex of patients with depression. The technique was approved by the U.S. Food and Drug Administration (FDA) for the treatment of depression in 2008 and recognized in 2012 by Brazilian Council of Medicine as a valid medical procedure throughout the country.A estimulação magnética transcraniana (EMT) é uma técnica de neuromodulação não invasiva, com efeitos adversos mínimos e poucas contraindicações. O procedimento vem sendo utilizado no arsenal terapêutico dos pacientes com depressão, mostrando benefícios terapêuticos comprovados em pesquisas no mundo todo. O último guideline europeu publicado sobre o tema, em 2014, coloca a EMT repetitiva de alta frequência aplicada no córtex pré-frontal dorsolateral esquerdo para depressão como nível A de evidência (eficácia definida). A técnica foi aprovada pelo Food and Drug Administration nos EUA para tratamento de depressão em 2008 e reconhecida em 2012 pelo Conselho Federal de Medicina como ato médico válido em todo o território nacional.Associação Brasileira de Psiquiatria2016-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-ReviewedRevisado por ParesAvaliado Pelos Paresapplication/pdfhttps://revistardp.org.br/revista/article/view/13110.25118/2236-918X-6-3-3Debates in Psychiatry; Vol. 6 No. 3 (2016); 23-36Debates em Psiquiatria; Vol. 6 Núm. 3 (2016); 23-36Debates em Psiquiatria; v. 6 n. 3 (2016); 23-362763-90372236-918Xreponame:Debates em Psiquiatria (Online)instname:Associação Brasileira de Psiquiatria (ABP)instacron:ABPporhttps://revistardp.org.br/revista/article/view/131/115https://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessMontenegro, Maria CristinaCantilino, Amaury2021-12-15T23:40:09Zoai:ojs.emnuvens.com.br:article/131Revistahttps://revistardp.org.br/revista/oaiPUBhttps://revistardp.org.br/revista/oairdp@abp.org.br2763-90372236-918Xopendoar:2021-12-15T23:40:09Debates em Psiquiatria (Online) - Associação Brasileira de Psiquiatria (ABP)false
dc.title.none.fl_str_mv Transcranial magnetic stimulation: what should psychiatrists know?
Estimulação magnética transcraniana: o que o psiquiatra deve saber?
title Transcranial magnetic stimulation: what should psychiatrists know?
spellingShingle Transcranial magnetic stimulation: what should psychiatrists know?
Montenegro, Maria Cristina
Estimulação magnética transcraniana
neuromodulação
depressão maior
Transcranial magnetic stimulation
neuromodulation
major depressive disorder
title_short Transcranial magnetic stimulation: what should psychiatrists know?
title_full Transcranial magnetic stimulation: what should psychiatrists know?
title_fullStr Transcranial magnetic stimulation: what should psychiatrists know?
title_full_unstemmed Transcranial magnetic stimulation: what should psychiatrists know?
title_sort Transcranial magnetic stimulation: what should psychiatrists know?
author Montenegro, Maria Cristina
author_facet Montenegro, Maria Cristina
Cantilino, Amaury
author_role author
author2 Cantilino, Amaury
author2_role author
dc.contributor.author.fl_str_mv Montenegro, Maria Cristina
Cantilino, Amaury
dc.subject.por.fl_str_mv Estimulação magnética transcraniana
neuromodulação
depressão maior
Transcranial magnetic stimulation
neuromodulation
major depressive disorder
topic Estimulação magnética transcraniana
neuromodulação
depressão maior
Transcranial magnetic stimulation
neuromodulation
major depressive disorder
description Transcranial magnetic stimulation (TMS) is a noninvasive neuromodulation technique with minimal adverse effects and few contraindications. The procedure has been used in the treatment of patients with depression, with proven therapeutic benefits as shown in studies conducted worldwide. The latest European guideline published on the topic, in 2014, assigns evidence level A (defined efficacy) to high-frequency repetitive TMS applied over the left prefrontal dorsolateral cortex of patients with depression. The technique was approved by the U.S. Food and Drug Administration (FDA) for the treatment of depression in 2008 and recognized in 2012 by Brazilian Council of Medicine as a valid medical procedure throughout the country.
publishDate 2016
dc.date.none.fl_str_mv 2016-06-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-Reviewed
Revisado por Pares
Avaliado Pelos Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistardp.org.br/revista/article/view/131
10.25118/2236-918X-6-3-3
url https://revistardp.org.br/revista/article/view/131
identifier_str_mv 10.25118/2236-918X-6-3-3
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistardp.org.br/revista/article/view/131/115
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
dc.source.none.fl_str_mv Debates in Psychiatry; Vol. 6 No. 3 (2016); 23-36
Debates em Psiquiatria; Vol. 6 Núm. 3 (2016); 23-36
Debates em Psiquiatria; v. 6 n. 3 (2016); 23-36
2763-9037
2236-918X
reponame:Debates em Psiquiatria (Online)
instname:Associação Brasileira de Psiquiatria (ABP)
instacron:ABP
instname_str Associação Brasileira de Psiquiatria (ABP)
instacron_str ABP
institution ABP
reponame_str Debates em Psiquiatria (Online)
collection Debates em Psiquiatria (Online)
repository.name.fl_str_mv Debates em Psiquiatria (Online) - Associação Brasileira de Psiquiatria (ABP)
repository.mail.fl_str_mv rdp@abp.org.br
_version_ 1796798367435587584

Registros relacionados